NEW YORK, March 6 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb
Company (NYSE: BMY) announced today that its Board of Directors has elected
Michael Grobstein, retired Vice Chairman, Ernst & Young, to the Board. His
appointment is effective today. Grobstein will serve as a member of the
Audit Committee.
Grobstein, 64, was employed by Ernst & Young for 34 years. During his
career there, he held various client service and management positions,
including serving as a Vice Chairman for 14 years until his retirement from
the firm. Grobstein currently is on the Board of Given Imaging Ltd., where
he is chairman of the Executive Committee and the Audit Committee. He also
served as chairman of the Audit Committee of Guidant Corporation until it
was acquired by Boston Scientific.
"Bristol-Myers Squibb will benefit greatly from Mike's breadth of
financial and business experience," said James D. Robinson III, chairman,
Bristol-Myers Squibb. "We are looking forward to his expertise and insight
as a key member of the Audit Committee."
Bristol-Myers Squibb is a global pharmaceutical and related healthcare
products company whose mission is to extend and enhance human life.
SOURCE Bristol-Myers Squibb Company
 back to top
Related links:
http://www.bms.com
CONTACT:
Media\Communications: Tony Plohoros,
+1-609-252-7938, tony.plohoros@bms.com, or Jeff Macdonald,
+1-212-546-4824, jeffrey.macdonald@bms.com, or Investors\Investor
Relations: John Elicker, +1-212-546-3775, john.elicker@bms.com,
or Blaine Davis, +1-609-252-7445, blaine.davis@bms.com, all of
Bristol-Myers Squibb Company
|
